CBZ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
CBIZ Inc (CBZ) does not present a strong buy opportunity for a beginner investor with a long-term strategy at this time. While the stock has shown some recent positive momentum and analysts have noted potential for long-term growth, the company's financial performance, hedge fund selling, and lack of strong proprietary trading signals suggest it is better to hold off on investing until clearer positive trends emerge.
The MACD is positive and expanding, indicating bullish momentum. However, the RSI is in the neutral zone at 77.79, and moving averages are converging, suggesting no clear trend. The stock is trading near its resistance level (R1: 30.477), which could limit immediate upside potential.
Analysts note that the recent selloff has created an attractive entry point.
The company's Marcum acquisition has expanded its market share and recurring revenue base.
Appointment of Peter Scavuzzo as CIO, with expertise in AI and enterprise transformation, could enhance the company's competitive position.
Hedge funds are selling heavily, with a 1593.40% increase in selling over the last quarter.
Financial performance in Q4 2025 showed a decline in net income (-12.46% YoY), EPS (-16.34% YoY), and gross margin (-25.56% YoY).
Analysts expect the company to trade at a trough multiple until AI fears and revenue growth concerns are resolved.
In Q4 2025, revenue increased by 17.90% YoY to $542.66M, but net income dropped to -$79.42M (-12.46% YoY), EPS fell to -1.28 (-16.34% YoY), and gross margin declined by 25.56%. This indicates growth in revenue but significant profitability challenges.
Analysts are mixed: BMO Capital rates it Outperform with a $33 price target, citing long-term demand and an attractive entry point. Stephens rates it Equal Weight with a $31 price target, noting concerns about AI fears and revenue guidance. Deutsche Bank lowered its price target from $60 to $40, maintaining a Hold rating.
